Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Humphreys

Showing results (401-410 of 450) with videos related to

Pageof 45
Sort By:
Plos Genetics|May 3, 2011
GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphomaKarin E Smedby, Jia Nee Foo, Christine F Skibola, et al.
Nature Genetics|July 20, 2010
Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32Lucia Conde, Eran Halperin, Nicholas K Akers, et al.
Cancers|July 14, 2023
Spectrum and Frequency of Germline <i>FANCM</i> Protein-Truncating Variants in 44,803 European Female Breast Cancer CasesGisella Figlioli, Amandine Billaud, Qin Wang, et al.
American Journal of Human Genetics|February 24, 2023
The impact of coding germline variants on contralateral breast cancer risk and survivalAnna Morra, Nasim Mavaddat, Taru A Muranen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 10, 2010
Missense variants in ATM in 26,101 breast cancer cases and 29,842 controlsOlivia Fletcher, Nichola Johnson, Isabel dos Santos Silva, et al.
International Journal of Cancer|September 18, 2014
Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factorsAnja Rudolph, Roger L Milne, Thérèse Truong, et al.
European Journal of Human Genetics : EJHG|January 27, 2023
FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European womenGisella Figlioli, Amandine Billaud, Thomas U Ahearn, et al.
Breast Cancer Research : BCR|April 8, 2015
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapyJieping Lei, Anja Rudolph, Kirsten B Moysich, et al.
Pain Medicine (Malden, Mass.)|November 30, 2018
International Stakeholder Community of Pain Experts and Leaders Call for an Urgent Action on Forced Opioid TaperingBeth D Darnall, David Juurlink, Robert D Kerns, et al.
Nature Communications|June 18, 2014
2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapyJingmei Li, Linda S Lindström, Jia N Foo, et al.
Pageof 45

Showing results (401-410 of 450) with videos related to

Sort By:
Pageof 45
Plos Genetics|May 3, 2011
GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphomaKarin E Smedby, Jia Nee Foo, Christine F Skibola, et al.
Nature Genetics|July 20, 2010
Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32Lucia Conde, Eran Halperin, Nicholas K Akers, et al.
Cancers|July 14, 2023
Spectrum and Frequency of Germline <i>FANCM</i> Protein-Truncating Variants in 44,803 European Female Breast Cancer CasesGisella Figlioli, Amandine Billaud, Qin Wang, et al.
American Journal of Human Genetics|February 24, 2023
The impact of coding germline variants on contralateral breast cancer risk and survivalAnna Morra, Nasim Mavaddat, Taru A Muranen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 10, 2010
Missense variants in ATM in 26,101 breast cancer cases and 29,842 controlsOlivia Fletcher, Nichola Johnson, Isabel dos Santos Silva, et al.
International Journal of Cancer|September 18, 2014
Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factorsAnja Rudolph, Roger L Milne, Thérèse Truong, et al.
European Journal of Human Genetics : EJHG|January 27, 2023
FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European womenGisella Figlioli, Amandine Billaud, Thomas U Ahearn, et al.
Breast Cancer Research : BCR|April 8, 2015
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapyJieping Lei, Anja Rudolph, Kirsten B Moysich, et al.
Pain Medicine (Malden, Mass.)|November 30, 2018
International Stakeholder Community of Pain Experts and Leaders Call for an Urgent Action on Forced Opioid TaperingBeth D Darnall, David Juurlink, Robert D Kerns, et al.
Nature Communications|June 18, 2014
2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapyJingmei Li, Linda S Lindström, Jia N Foo, et al.
Pageof 45